Search Results for 'Pembrolizumab'

Pembrolizumab published presentations and documents on DocSlides.

Incorporating Immunotherapy in management of HNSCC

Incorporating Immunotherapy in management of HNSCC

by candy

ندوة أورام الرأس . و. العنق. ...

Immunotherapy in Endometrial Cancer: Expanding Horizons

Immunotherapy in Endometrial Cancer: Expanding Horizons

by rose

Emily Hinchcliff MD MPH. Assistant Professor, Gyne...

Please refer to CCMB Formulary for Criteria for Use

Please refer to CCMB Formulary for Criteria for Use

by anya

ADULT Updated: November 20 , 2020 Page 1 of 2 R...

Please note, these are the

Please note, these are the

by disclaimercanon

actual. . video-recorded proceedings from the . l...

Expanding Treatment Options in SCCHN: What Role Do Cancer Immunotherapies Have?

Expanding Treatment Options in SCCHN: What Role Do Cancer Immunotherapies Have?

by marina-yarberry

Expanding Treatment Options in SCCHN: What Role D...

Raising the Bar in the Management of Advanced/Metastatic NSCLC

Raising the Bar in the Management of Advanced/Metastatic NSCLC

by debby-jeon

Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...

Uterine Leiomyosarcoma A Case Presentation

Uterine Leiomyosarcoma A Case Presentation

by tatiana-dople

Patient Presentation. 58 year-old female with his...

Year in Review — Clinical Investigators Provide Perspectives on the Most Relevant New Publication

Year in Review — Clinical Investigators Provide Perspectives on the Most Relevant New Publication

by obrien

Nontargeted Therapy for Lung Cancer. Tuesday, Janu...

Dario R. Roque, MD Endometrial Cancer &

Dario R. Roque, MD Endometrial Cancer &

by osullivan

Lynch Syndrome. Endometrial Cancer 2020. Estimated...

Immunotherapy for advanced cervical cancer

Immunotherapy for advanced cervical cancer

by elizabeth

Megan Swanson, MD MPH. Assistant Professor. Gyneco...

ANPROMUKPIP0001

ANPROMUKPIP0001

by dorothy

1C-January 2021An Attributionof Value Frameworkfor...

Please note, these are the

Please note, these are the

by vizettan

actual. . video-recorded proceedings from the . l...

Please note, these are the

Please note, these are the

by robaut

actual. . video-recorded proceedings from the . l...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

by chaptoe

proceedings from the live CME event and may includ...

Module 12: Gynecologic Cancers

Module 12: Gynecologic Cancers

by broadcastworld

Paula J Anastasia, RN, MN, AOCN. Kathleen Moore, M...

Advances in Gastrointestinal Cancers

Advances in Gastrointestinal Cancers

by lindy-dunigan

This program will include a discussion of data th...

Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in

Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in

by yoshiko-marsland

Pan Tumors. This program will include a discussio...

Novel Agents in Multiple Myeloma

Novel Agents in Multiple Myeloma

by marina-yarberry

The Pharmacist's View on Therapy . Learning Objec...

Updates in Lymphoma From Recent Congresses

Updates in Lymphoma From Recent Congresses

by lindy-dunigan

Therapeutic Targets in CLL. Venetoclax in Patient...

Michelle Boisen , MD Assistant professor of Gynecologic oncology

Michelle Boisen , MD Assistant professor of Gynecologic oncology

by calandra-battersby

Magee-. Womens. Hospital of UPMC. Clinical and R...

Symptom Management of Novel Agents

Symptom Management of Novel Agents

by yoshiko-marsland

Amanda Dean, MSN, ACNP-BC, RNFA. Director of Adva...

An APC activator (IMP321 or LAG-3Ig) combined with anti-PD

An APC activator (IMP321 or LAG-3Ig) combined with anti-PD

by yoshiko-marsland

Frédéric Triebel, M.D., PhD. , Prima Biomed Ltd...